Company Short-Term Debt: codiagnostics.com (CODX)

Public company logo of Co-Diagnostics (CODX)

The decline in post-pandemic demand is forcing Co-Diagnostics, Inc. (CODX) to aggressively optimize expenses, although the absence of loans stabilizes the business. Diversification of diagnostic systems for medicine and veterinary care in Europe and the US reduces risks. The use of contract manufacturing and the external IT sector accelerates the delivery of results. This chart of current short-term loans demonstrates financial stability, where the 0.00 metric determines this level.

CODX (Co-Diagnostics) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company CoDx (CODX)

- stock price and consensus target price:
Stock Price Co-Diagnostics|CODX - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Co-Diagnostics, Inc.|CODX - Business Value
- shareholders' equity book value data:
Book Value per Share Co-Diagnostics|CODX - Book Capitalization|Market Value to Book Value Ratio codiagnostics.com|CODX - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Co-Diagnostics, Inc.|CODX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Co-Diagnostics, Inc.|CODX - Company Total Debt Obligations|Debts to Book Capitalization Co-Diagnostics, Inc.|CODX - Long-Term Debt Volume|Company Short-Term Debt Co-Diagnostics|Quick Ratio codiagnostics.com
- net income and valuation multiples indicators:
CODX - Net Income
Fundamental company analysis:Co-Diagnostics (CODX)
Flagship merchandise of Co-Diagnostics, Inc.

To protect capital during periods of volatility, it is critical to assess liabilities with maturities of up to twelve months, which measure the current liquidity and solvency of a business. By analyzing short-term debt with a maturity of up to one year, an investor determines the ability of Co-Diagnostics, Inc. (CODX) to service its debts amid declining revenue from pandemic testing and fierce competition in molecular diagnostics.

Competitors of Co-Diagnostics, Inc.

Agilent - Company Short-Term Debts|DGX - Company Short-Term Debts|Illumina Corp (ILMN) - Company Short-Term Debt|Company Short-Term Indebtedness EXAS|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts bio-rad.com|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt SHC (Sotera Health Corp)|QuidelOrtho Corp - Company Current Liabilities|OPKO Health Corp. (OPK) - Short-Term Debt|CDNA - Company Short-Term Debt|Short-Term Debt Volume maravai.com MRVI|FLGT: Company Short-Term Debts|LAB - Short-Term Debt Volume|Company Short-Term Debt Cytek Bio|OraSure Corp (OSUR) - Short-Term Debt Volume|Company Short-Term Debts XGN|Company Current Liabilities mdxhealth.com MDXH|Company Short-Term Debt Lucid Diagnostics LUCD|Prenetics Global Limited (PRE) - Short-Term Debt|IMDX: Company Current Liabilities|Short-Term Indebtedness Trinity Biotech plc (TRIB)|PRPH: Company Short-Term Debts|Company Short-Term Indebtedness AIMD|HSCS (HeartSciences) - Company Short-Term Debts|Biomerica Inc. (BMRA) - Short-Term Debt Volume|Company Short-Term Debts CDIO|Company Short-Term Debts Virax Biolabs Corp (VRAX)|Company Short-Term Debts BJDX (Bluejay Diagnostics)|Short-Term Indebtedness aspirawh.com|AXDX - Company Short-Term Debt|CNTG (CENTOGENE N.V.) - Company Short-Term Indebtedness|enzo.com (ENZ) - Company Short-Term Debt|Short-Term Debt Fresh2 Group (FRES)|Company Short-Term Debt Genetic Technologies Ltd|23andme.com (ME) - Short-Term Debt Volume|Company Current Liabilities PMD (Psychemedics Corporation)